NM_000208.4:c.101-966T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000208.4(INSR):​c.101-966T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.277 in 151,948 control chromosomes in the GnomAD database, including 6,258 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.28 ( 6258 hom., cov: 30)

Consequence

INSR
NM_000208.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.01

Publications

1 publications found
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
  • insulin-resistance syndrome type A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • Donohue syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • hyperinsulinism due to INSR deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
  • Rabson-Mendenhall syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.326 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INSRNM_000208.4 linkc.101-966T>C intron_variant Intron 1 of 21 ENST00000302850.10 NP_000199.2 P06213-1
INSRNM_001079817.3 linkc.101-966T>C intron_variant Intron 1 of 20 NP_001073285.1 P06213-2
INSRXM_011527988.3 linkc.101-966T>C intron_variant Intron 1 of 21 XP_011526290.2
INSRXM_011527989.4 linkc.101-966T>C intron_variant Intron 1 of 20 XP_011526291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INSRENST00000302850.10 linkc.101-966T>C intron_variant Intron 1 of 21 1 NM_000208.4 ENSP00000303830.4 P06213-1
INSRENST00000341500.9 linkc.101-966T>C intron_variant Intron 1 of 20 1 ENSP00000342838.4 P06213-2
INSRENST00000598216.1 linkn.76-966T>C intron_variant Intron 1 of 9 1

Frequencies

GnomAD3 genomes
AF:
0.277
AC:
42097
AN:
151828
Hom.:
6256
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.200
Gnomad AMI
AF:
0.493
Gnomad AMR
AF:
0.214
Gnomad ASJ
AF:
0.256
Gnomad EAS
AF:
0.258
Gnomad SAS
AF:
0.300
Gnomad FIN
AF:
0.321
Gnomad MID
AF:
0.310
Gnomad NFE
AF:
0.329
Gnomad OTH
AF:
0.284
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.277
AC:
42112
AN:
151948
Hom.:
6258
Cov.:
30
AF XY:
0.275
AC XY:
20442
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.200
AC:
8292
AN:
41444
American (AMR)
AF:
0.214
AC:
3263
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
0.256
AC:
889
AN:
3470
East Asian (EAS)
AF:
0.258
AC:
1331
AN:
5168
South Asian (SAS)
AF:
0.300
AC:
1449
AN:
4824
European-Finnish (FIN)
AF:
0.321
AC:
3385
AN:
10554
Middle Eastern (MID)
AF:
0.303
AC:
89
AN:
294
European-Non Finnish (NFE)
AF:
0.329
AC:
22361
AN:
67940
Other (OTH)
AF:
0.287
AC:
606
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1495
2989
4484
5978
7473
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
448
896
1344
1792
2240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.305
Hom.:
11852
Bravo
AF:
0.263
Asia WGS
AF:
0.300
AC:
1044
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.3
DANN
Benign
0.72
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62109585; hg19: chr19-7268873; API